← Leaderboards
Thomas N Mather
University Of Rhode Island
$6,509,277
Attributed
$7,528,909
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $669K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,208,490 · 3
CDC$3,320,419 · 3
By mechanism
R01$4,492,443 · 2
U19$1,324,852 · 1
U01$1,281,155 · 2
R21$430,459 · 1
Top collaborators
- Steven Richard Meshnick4 shared
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentSalivaProteomicsSalivary GlandsLyme DiseaseBacterial VaccinesBacterial ProteinsLaboratory MouseRecombinant ProteinsBorreliaTicksIxodesHost Organism InteractionPeromyscusCommunicable Disease TransmissionHuman SubjectMolecular CloningBactericidal ImmunityAffinityBacterial GeneticsAntigensBlack-Legged TickBiteBioterrorism
Grant awards (23)
Preventing Lyme Disease Exposure Among Outdoor Workers$498,296
R01 · FY2018 · OH · contact PI
Preventing Lyme Disease Exposure Among Outdoor Workers$509,609
R01 · FY2017 · OH · contact PI
Preventing Lyme Disease Exposure Among Outdoor Workers$503,698
R01 · FY2016 · OH · contact PI
Preventing Lyme Disease Exposure Among Outdoor Workers$527,661
R01 · FY2015 · OH · contact PI
Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce$300,000
U01 · FY2013 · CK · contact PI
Immuno-Proteomic Approach to Anti-Tick Vaccine Development$210,922
U19 · FY2013 · AI · contact PI
Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce$299,994
U01 · FY2012 · CK · contact PI
Immuno-Proteomic Approach to Anti-Tick Vaccine Development$295,258
U19 · FY2012 · AI · contact PI
Ability of Individual and Integrated Tick Management (ITM) Technologies to Reduce$291,643
U01 · FY2011 · CK · contact PI
Immuno-Proteomic Approach to Anti-Tick Vaccine Development$271,835
U19 · FY2011 · AI · contact PI
Immuno-Proteomic Approach to Anti-Tick Vaccine Development$279,013
U19 · FY2010 · AI · contact PI
Immuno-Proteomic Approach to Anti-Tick Vaccine Development$267,824
U19 · FY2009 · AI · contact PI
Assessing Community-Based Tick Control for LD Mitigation$189,765
U01 · FY2007 · CI · contact PI
Role of Tick Saliva in Lyme Disease and Vaccine Strategy$469,248
R01 · FY2006 · AI · contact PI
Assessing Community-Based Tick Control for LD Mitigation$199,753
U01 · FY2006 · CI · contact PI
Role of Tick Saliva in Lyme Disease and Vaccine Strategy$466,544
R01 · FY2005 · AI
Assessing Community-Based Tick Control for LD Mitigation$0
U01 · FY2005 · CI
Role of Tick Saliva in Lyme Disease and Vaccine Strategy$452,955
R01 · FY2004 · AI
Assessing Community-Based Tick Control for LD Mitigation$0
U01 · FY2004 · CI
Role of Tick Saliva in Lyme Disease and Vaccine Strategy$450,348
R01 · FY2003 · AI
Role of Tick Saliva in Lyme Disease and Vaccine Strategy$287,774
R01 · FY2002 · AI
ROLE OF TICK SALIVA IN LYME DISEASE AND VACCINE STRATEGY$430,459
R21 · FY2001 · AI
TICK SALIVA AND LYME DISEASE AND VACCINE STRATEGY$326,310
R01 · FY2000 · AI